TipRanks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market
SVA
Sinovac Biotech
RESEARCH TOOLSreports
Want to see SVA full AI Analyst Report?

Sinovac Biotech (SVA) Income Statement

137 Followers

Sinovac Biotech Income Statement

Last quarter (Q1 2024), Sinovac Biotech's total revenue was $307.87M, a decrease of -96.33% from the same quarter last year. In Q1, Sinovac Biotech's net income was $-116.84M. See Sinovac Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 386.01M$ 448.27M$ 1.49B$ 19.37B$ 510.62M
Gross Profit
$ 261.98M$ 266.75M$ 808.30M$ 18.30B$ 443.44M
Operating Expenses
$ 553.30M$ 813.48M$ 1.27B$ 748.45M$ 227.64M
Depreciation and Amortization
$ 103.66M$ 144.75M$ 156.60M$ 100.43M$ 6.63M
EBITDA
$ -187.66M$ -6.03M$ 183.10M$ 17.65B$ 221.76M
Operating Income
$ -291.32M$ -546.72M$ -466.07M$ 17.55B$ 215.64M
Other Income/Expenses
$ 29.22M$ 393.69M$ 491.31M$ 9.78M$ 973.00K
Pretax Income
$ -262.10M$ -153.03M$ 25.24M$ 17.56B$ 216.62M
Net Income
$ -59.68M$ -99.92M$ 113.87M$ 8.47B$ 110.37M
Per Share Metrics
Basic EPS
$ -0.83$ -1.06$ 1.08$ 85.20$ 1.06
Diluted EPS
$ -0.83$ -1.06$ 1.00$ 74.27$ 0.97
Weighted Average Shares Outstanding
 71.86M 99.61M 99.50M 99.31M 98.90M
Weighted Average Shares Outstanding (Diluted)
 71.86M 99.61M 114.17M 114.01M 113.66M
Currency in USD

Sinovac Biotech Earnings and Revenue History